Tag Archives: Moderna

Britain First To Approve Booster That Targets Variants

Reuters reports: Britain has become the first country to approve a COVID-19 vaccine that targets both the original and Omicron variant of the virus. The the UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna as a booster for adults. The MHRA also cited an exploratory analysis in which the shot was also found …

Read More »

Moderna May Create mRNA-Based Monkeypox Vax

ABC News reports: Amid growing concerns over the potential threat of monkeypox, executives from Moderna said Wednesday they have initiated a research program to consider whether the company could create a monkeypox vaccine with mRNA technology. “We’re obviously very aware of the monkeypox concern and obviously very sensitive to recent announcements,” Moderna President Stephen Hoge said during an investor call. …

Read More »

Moderna Seeks Vax Approval For Children Under Six

The Associated Press reports: Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer. Frustrated families are waiting impatiently for a chance to protect the nation’s littlest kids as all around them people shed masks and other public …

Read More »

FDA Approves Second Booster For People Over Age 50

USA Today reports: People age 50 and up are now eligible for a second booster dose of COVID-19 vaccine at least four months after their first, the Food and Drug Administration said Tuesday. “Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine could help increase protection levels for these higher-risk …

Read More »

Moderna Seeks FDA Vax Approval For Children Under 6

NPR reports: Moderna is hoping to get the green light to administer a pediatric, low-dose COVID-19 vaccine for children ages 6 months to under 6 years of age, it said in a statement. The pharmaceutical company will submit a request to the Food and Drug Administration “in the coming weeks” for authorization for a two-dose, 25 microgram-each shot. That’s 25% …

Read More »

Moderna Seeks Fourth Dose Okay For Those Over 18

USA Today reports: Moderna on Thursday requested emergency use authorization from the Food and Drug Administration for a fourth dose of its COVID-19 vaccine as a booster for people 18 and over — a broader request than Pfizer made days ago for its vaccine. Currently, a single booster dose of Moderna’s mRNA vaccine is authorized for emergency use on top …

Read More »

FDA Grants Full Final Approval To Moderna Vaccine

The Washington Post reports: The Food and Drug Administration has granted full approval to Moderna’s coronavirus vaccine, the agency announced Monday. Moderna’s vaccine, now known as Spikevax, was previously available under emergency use authorization and is the second coronavirus vaccine to get full FDA approval. Pfizer and BioNTech’s product was approved in August. Moderna, a biotechnology company, said Monday that …

Read More »

Moderna Plans Combined Annual COVID/Flu Booster

Politico Europe reports: Moderna hopes to market a combined booster vaccination for COVID-19, influenza and RSV — a common respiratory virus — as soon as the fall of 2023, CEO Stéphane Bancel said Monday. Bancel, speaking on a panel at the World Economic Forum, said the combination vaccine would enable people to get broad protection against illnesses caused by respiratory …

Read More »

Moderna Booster Highly Effective Against Omicron

CNBC reports: Moderna announced Monday that a third dose of its mRNA vaccine against Covid-19 appears to provide significant protection against the omicron variant. Moderna said that its currently authorized booster can “boost neutralizing antibody levels 37-fold higher than pre-boost levels,” which it described as reassuring. However, it also said that a double doze of the booster shot — 100 …

Read More »

AP: Vaccine Makers Racing To Update Their Shots

The Associated Press reports: Vaccine makers are racing to update their COVID-19 shots against the newest coronavirus threat even before it’s clear a change is needed, just in case. Experts doubt today’s shots will become useless but say it’s critical to see how fast companies could produce a reformulated dose and prove it works — because whatever happens with omicron, …

Read More »

Moderna: Omicron Vax May Be Ready In Early 2022

Bloomberg News reports: Moderna Inc. Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year. “We should know about the ability of the current vaccine to provide protection in the next couple of weeks,” Burton said Sunday on the …

Read More »

FDA Approves Pfizer, Moderna Boosters For All Adults

The Washington Post reports: Federal regulators on Friday authorized Pfizer-BioNTech and Moderna coronavirus vaccine boosters for all adults, a one-size-fits-all strategy designed to shore up Americans’ defenses against a tenacious virus and reduce confusion over guidelines that have varied based on people’s age, occupation and where they live. The Food and Drug Administration cleared the boosters for people 18 and …

Read More »

CDC Approves Fourth Shot For Immuno-Compromised

Axios reports: The Centers for Disease Control and Prevention said in updated guidelines Tuesday that some immuno compromised people who have received either Pfizer or Moderna’s COVID-19 vaccines will be able to get a fourth shot. People over 18 who are “moderately to severely immuno compromised” and have received three doses of an mRNA vaccine may get a fourth shot …

Read More »

STUDY: Moderna Vaccine Effective In Kids Ages 5-11

NPR reports: Moderna says a study in kids 6 to 11 found two doses of the company’s COVID-19 vaccine given 28 days apart produced a strong antibody response. The study, conducted in collaboration with the National Institutes of Health, used shots containing a 50 microgram dose of the vaccine, half the dose of the Moderna shots authorized for adults. More …

Read More »

FDA Approves Moderna And J&J Vaccine Boosters

CNBC reports: The Food and Drug Administration Wednesday night authorized booster shots of both Johnson & Johnson and Moderna’s Covid vaccines, another critical step in distributing extra doses to tens of millions of people. At the same time, U.S. regulators also authorized “mixing and matching” vaccines, allowing Americans to get a booster shot that’s a different vaccine from the one …

Read More »

FDA To Allow “Mix And Match” For Booster Shots

The New York Times reports: The Food and Drug Administration is planning to allow Americans to receive a different Covid-19 vaccine as a booster than the one they initially received, a move that could reduce the appeal of the Johnson & Johnson vaccine and provide flexibility to doctors and other vaccinators. The government would not recommend one shot over another, …

Read More »

FDA Advisory Panel Recommends Moderna Booster

The New York Times reports: A key advisory committee to the Food and Drug Administration voted on Thursday to recommend a booster shot of the Moderna coronavirus vaccine for many of the vaccine’s recipients, at least six months after a second dose. The panel endorsed a half-dose as a third injection for people 65 and older as well as younger …

Read More »

FDA Set To Approve Moderna And J&J Booster Shots

The New York Times reports: The federal government is expected to take a significant step this week toward offering booster doses to a much wider range of Americans as advisers to the Food and Drug Administration meet on Thursday and Friday to discuss recipients of the Johnson & Johnson and Moderna coronavirus vaccines. On Thursday, the F.D.A.’s advisory panel of …

Read More »

Moderna: Booster Candidate “Robust” Against Delta

CNBC reports: Moderna said its Covid-19 vaccine booster shot produced a “robust” antibody response against the highly contagious delta variant, according to details of a study released Thursday with the company’s second-quarter earnings report. In a phase two trial, Moderna is testing a 50-microgram dose of three vaccine booster candidates in previously vaccinated individuals. The booster shots produced a promising …

Read More »

Moderna Reports Vaccine Is 100% Effective In Teens

CNBC reports: Moderna said Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer’s to demonstrate high efficacy in younger age groups. The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next …

Read More »